<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-147469" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Chromium Toxicity</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Reif</surname>
            <given-names>Brandon M.</given-names>
          </name>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Murray</surname>
            <given-names>Brian P.</given-names>
          </name>
          <aff>Wright State University Boonshoft School of Medicine</aff>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Brandon Reif declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Brian Murray declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>11</day>
          <month>1</month>
          <year>2024</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-147469.s1" sec-type="pubmed-excerpt">
        <title>Introduction</title>
        <p>Chromium (Cr; Atomic number 24) is a naturally occurring 3d-transition element. Chromium is Earth's seventh most abundant element at an average concentration of 125 mg/kg in Earth's crust.<xref ref-type="bibr" rid="article-147469.r1">[1]</xref><xref ref-type="bibr" rid="article-147469.r2">[2]</xref>&#x000a0;The oxidation states of chromium range from -4 to +6; the most stable forms are trivalent chromium [Cr(III)] and hexavalent chromium [Cr(VI)]. Chromium also exists in the environment as Cr(0), which is chromium metal. Cr(VI) is more soluble in water&#x000a0;than Cr(III) and 100 times more toxic.<xref ref-type="bibr" rid="article-147469.r1">[1]</xref><xref ref-type="bibr" rid="article-147469.r2">[2]</xref><xref ref-type="bibr" rid="article-147469.r3">[3]</xref><xref ref-type="bibr" rid="article-147469.r4">[4]</xref></p>
        <p>The toxicity associated with chronic chromate (CrO<sub>4</sub><sup>2-</sup>) exposure is well-documented and known for more than 200 years. Exposure to hexavalent chromium during World War II was linked to an increased risk of lung cancer.<xref ref-type="bibr" rid="article-147469.r5">[5]</xref>&#x000a0;</p>
        <p>Hexavalent chromium&#x000a0;was under scrutiny in the 1980s secondary to environmental contamination of groundwater, causing widespread public exposure and millions of dollars in property damage.<xref ref-type="bibr" rid="article-147469.r6">[6]</xref>&#x000a0;In recognition of the severity of its occupational and environmental hazards, chromium is regulated by multiple agencies as a "known" or "probable" human carcinogen of "great public health significance," along with arsenic, cadmium, lead, and mercury.<xref ref-type="bibr" rid="article-147469.r3">[3]</xref></p>
      </sec>
      <sec id="article-147469.s2" sec-type="Etiology">
        <title>Etiology</title>
        <p>Chromium metal is prized for its luster and corrosion resistance; Cr(0) is used to make steel.<xref ref-type="bibr" rid="article-147469.r6">[6]</xref><xref ref-type="bibr" rid="article-147469.r7">[7]</xref>&#x000a0;Trivalent and hexavalent chromium have other industrial applications, including coal and oil refining, metal and ore processing, leather tanning, dye and pigment production, welding, cement production, ammunition, agricultural fertilizers, and wood preservation.<xref ref-type="bibr" rid="article-147469.r2">[2]</xref><xref ref-type="bibr" rid="article-147469.r3">[3]</xref><xref ref-type="bibr" rid="article-147469.r4">[4]</xref><xref ref-type="bibr" rid="article-147469.r8">[8]</xref>&#x000a0;Nonoccupational sources of chromium exposure occur primarily&#x000a0;by consuming contaminated food and drinking water or exposure to tobacco-containing products that contain chromium released by pyrolysis.<xref ref-type="bibr" rid="article-147469.r1">[1]</xref><xref ref-type="bibr" rid="article-147469.r9">[9]</xref><xref ref-type="bibr" rid="article-147469.r10">[10]</xref><xref ref-type="bibr" rid="article-147469.r11">[11]</xref>&#x000a0;</p>
        <p>Historically, there were concerns of potential chromium toxicity secondary to implanting metal-on-metal chromium-cobalt hip arthroplasty components. Symptoms did not correlate with serum chromium concentrations, and more recent findings suggest the observed toxicity is more likely due to cobalt exposure.<xref ref-type="bibr" rid="article-147469.r12">[12]</xref>&#x000a0;These components have been redeveloped recently, reducing concerns&#x000a0;with modern medical devices.</p>
        <p>Not all chromium exposure is hazardous. Trivalent chromium has been classified as an essential micronutrient since the 1950s, with a recommended intake of 120 mcg/d due to its role in glucose and lipid metabolism. However, numerous nutritional supplements containing Cr(III) are marketed for weight loss and glucose regulation.<xref ref-type="bibr" rid="article-147469.r4">[4]</xref><xref ref-type="bibr" rid="article-147469.r9">[9]</xref><xref ref-type="bibr" rid="article-147469.r6">[6]</xref><xref ref-type="bibr" rid="article-147469.r7">[7]</xref>&#x000a0;Recent research&#x000a0;disputes the essentiality of trivalent chromium;&#x000a0;some studies suggest that compounds containing Cr(III) are potentially toxic and carcinogenic.<xref ref-type="bibr" rid="article-147469.r7">[7]</xref><xref ref-type="bibr" rid="article-147469.r10">[10]</xref><xref ref-type="bibr" rid="article-147469.r13">[13]</xref><xref ref-type="bibr" rid="article-147469.r14">[14]</xref>&#x000a0;</p>
        <p>Nevertheless, chromium supplements, particularly chromium picolinate and chromium chloride,&#x000a0;are popular with consumers, increasing from the fourth-highest&#x02013;selling vitamin and mineral supplements in 2016 to the second-highest in 2021.<xref ref-type="bibr" rid="article-147469.r10">[10]</xref><xref ref-type="bibr" rid="article-147469.r14">[14]</xref></p>
      </sec>
      <sec id="article-147469.s3" sec-type="Epidemiology">
        <title>Epidemiology</title>
        <p>Chromium is naturally ubiquitous and can be found in volcanic emissions, rocks, animals, plants, soil, and water. Chromium concentrations in uncontaminated water range from 1 &#x003bc;g/L to 10 &#x003bc;g/L in rivers and lakes to 0.2 &#x003bc;g/L to 1 &#x003bc;g/L in rainwater, and approximately 0.3 &#x003bc;g/L in seawater.<xref ref-type="bibr" rid="article-147469.r1">[1]</xref>&#x000a0;Estimated chromium concentrations in the air in rural and residential areas range from 0.2 ng/m<sup>3&#x000a0;</sup>to 9 ng/m<sup>3</sup> but can be 10 to 100 times higher in urban areas, equating to a lung intake of 1.8 &#x003bc;g/d.<xref ref-type="bibr" rid="article-147469.r11">[11]</xref>&#x000a0;Unsurprisingly, chromium is found in many foodstuffs, especially meat, fish, fruits, and vegetables, with estimated concentrations ranging from less than 10 &#x003bc;g/kg to 1,300 &#x003bc;g/kg.<xref ref-type="bibr" rid="article-147469.r1">[1]</xref><xref ref-type="bibr" rid="article-147469.r3">[3]</xref></p>
        <p>However, worldwide industrial processes produce more than 16.4 million tons of chromium annually. More than 170,000 tons are produced annually in the United States, of which 900 to 970 tons are released into the air, and&#x000a0;almost 250 tons are discharged to surface water.<xref ref-type="bibr" rid="article-147469.r1">[1]</xref><xref ref-type="bibr" rid="article-147469.r2">[2]</xref><xref ref-type="bibr" rid="article-147469.r11">[11]</xref>&#x000a0;Additionally, environmental contaminants discharged from the 386 National Priority List hazardous waste sites known to contain high levels of Cr(VI) are estimated to be&#x000a0;45,000 tons&#x000a0;annually, equated by one study to as much as 3,000 mg/kg in soil, 800 &#x003bc;g/L in seawater, and 5,200 &#x003bc;g/L in rivers and lakes.<xref ref-type="bibr" rid="article-147469.r11">[11]</xref><xref ref-type="bibr" rid="article-147469.r3">[3]</xref>&#x000a0;Consequently, the United States Environmental Protection Agency (EPA) has set a water safety standard of 0.1 mg/L or 100 ppb for total chromium, and the State of California has set a public health goal of 20 ng/L or 0.02 ppb for hexavalent chromium.<xref ref-type="bibr" rid="article-147469.r1">[1]</xref><xref ref-type="bibr" rid="article-147469.r6">[6]</xref>&#x000a0;The World Health Organization is more conservative than the EPA in its safety standard, recommending no more than 0.05 mg/L or 50 ppb of Cr(VI) in drinking water.<xref ref-type="bibr" rid="article-147469.r9">[9]</xref></p>
        <p>Over 110 million workers worldwide are exposed annually to welding fumes&#x000a0;that frequently contain Cr(VI). In the United States, more than 550,000 welders are exposed to Cr(VI)-containing metal fumes annually, and more than 1 million construction workers are exposed to cement and grout.<xref ref-type="bibr" rid="article-147469.r13">[13]</xref>&#x000a0;A&#x000a0;recent meta-analysis&#x000a0;demonstrated that 11,564 of 973,697 workers with occupational exposure to Cr(VI) across multiple occupations and countries had at least&#x000a0;1 kind of cancer, resulting in an overall prevalence of 1.17%.<xref ref-type="bibr" rid="article-147469.r15">[15]</xref>&#x000a0;</p>
        <p>Numerous government agencies have set acceptable standards for chromium exposure. The Occupational Safety and Health Administration (OSHA)&#x000a0;permits daily levels of 0.5 mg/m<sup>3</sup> in air for Cr(III) and 0.005 mg/m<sup>3</sup> for Cr(VI). The National Institute for Occupational Safety and Health (NIOSH) recommends a more stringent standard of 0.001 mg/m<sup>3</sup> for Cr(VI).<xref ref-type="bibr" rid="article-147469.r6">[6]</xref>&#x000a0;The European Union and nations like China and the United Kingdom have also set occupational exposure limits for chromium,&#x000a0;with the most stringent recommendations for&#x000a0;Cr(VI) exposure.<xref ref-type="bibr" rid="article-147469.r7">[7]</xref></p>
      </sec>
      <sec id="article-147469.s4" sec-type="Pathophysiology">
        <title>Pathophysiology</title>
        <p>Hexavalent chromium can enter cells as chromate through anion channels due to&#x000a0;its resemblance to sulfate and phosphate.<xref ref-type="bibr" rid="article-147469.r2">[2]</xref><xref ref-type="bibr" rid="article-147469.r3">[3]</xref><xref ref-type="bibr" rid="article-147469.r8">[8]</xref><xref ref-type="bibr" rid="article-147469.r9">[9]</xref>&#x000a0;Once inside the cell, antioxidant compounds such as ascorbate, glutathione, and cysteine, as well as enzymes such as superoxide dismutase and catalase, reduce Cr(VI) to&#x000a0;Cr(III)&#x000a0;via pentavalent and tetravalent intermediates.<xref ref-type="bibr" rid="article-147469.r1">[1]</xref><xref ref-type="bibr" rid="article-147469.r3">[3]</xref><xref ref-type="bibr" rid="article-147469.r9">[9]</xref><xref ref-type="bibr" rid="article-147469.r11">[11]</xref>&#x000a0;Ascorbate mediates 80% to 90% of these reduction reactions, with another 5% to 15% mediated by glutathione or cysteine.<xref ref-type="bibr" rid="article-147469.r1">[1]</xref><xref ref-type="bibr" rid="article-147469.r11">[11]</xref>&#x000a0;The toxic effects of Cr(VI) are exerted primarily through oxidative stress induced by the formation of intracellular reactive oxygen species such as superoxide, hydrogen peroxide, and hydroxyl radicals, as well as highly reactive intermediates.<xref ref-type="bibr" rid="article-147469.r2">[2]</xref><xref ref-type="bibr" rid="article-147469.r3">[3]</xref><xref ref-type="bibr" rid="article-147469.r7">[7]</xref><xref ref-type="bibr" rid="article-147469.r13">[13]</xref></p>
        <p>The unstable Cr(V) and Cr(IV), and the stable Cr(III) adduct with proteins and DNA, precipitate double- and single-stranded DNA breaks, and form DNA crosslinks via multiple mechanisms. These genetic mutations are dose-dependent and determined by the initial intracellular Cr(VI) concentration.<xref ref-type="bibr" rid="article-147469.r1">[1]</xref><xref ref-type="bibr" rid="article-147469.r3">[3]</xref><xref ref-type="bibr" rid="article-147469.r8">[8]</xref><xref ref-type="bibr" rid="article-147469.r9">[9]</xref>&#x000a0;Chromium intermediates and metabolites can induce cellular apoptosis, alter gene methylation, disrupt histone and micro-RNA regulation, induce microsatellite instability, and decrease p16 and p53 tumor suppression activity.<xref ref-type="bibr" rid="article-147469.r8">[8]</xref><xref ref-type="bibr" rid="article-147469.r11">[11]</xref><xref ref-type="bibr" rid="article-147469.r14">[14]</xref></p>
        <p>All forms of chromium exert their toxic effects primarily in the intracellular environment and are much less toxic when reduced to&#x000a0;Cr(III) extracellularly.<xref ref-type="bibr" rid="article-147469.r1">[1]</xref><xref ref-type="bibr" rid="article-147469.r9">[9]</xref><xref ref-type="bibr" rid="article-147469.r13">[13]</xref>&#x000a0;Between 80% to 90% of ingested Cr(VI) is reduced to Cr(III) in saliva and gastric juice at a capacity of 8 mg/L to 31 mg/L or approximately 80 mg/d; this is a significant protective mechanism against oral exposures.<xref ref-type="bibr" rid="article-147469.r1">[1]</xref>&#x000a0;</p>
        <p>Extracellular Cr(III) is often considered a micronutrient. Some studies propose Cr(III) interacts with tyrosine kinase insulin receptors, causes translocation of glucose transporter 4 (GLUT4) to the cell membrane, and increases AMP protein kinase (AMPK), all of which account for a preliminarily suggestive role in diabetes, metabolic syndrome, and PCOS.<xref ref-type="bibr" rid="article-147469.r7">[7]</xref>&#x000a0;However, other studies suggest potential long-term toxicity from Cr(III) supplementation due to potential reoxidation to higher valence forms and recommend against excessive supplement use.<xref ref-type="bibr" rid="article-147469.r14">[14]</xref></p>
        <p>
<bold>Pulmonary System</bold>
</p>
        <p>Pulmonary exposure to Cr(VI) via inhalation has been associated with the development of lung cancer, particularly with poorly soluble compounds. It is hypothesized that these poorly soluble compounds may adhere to the respiratory epithelium, dissolve slowly, and result in chronic genotoxic insults due to oxidative stress.<xref ref-type="bibr" rid="article-147469.r5">[5]</xref><xref ref-type="bibr" rid="article-147469.r11">[11]</xref>&#x000a0;Proposed mechanisms of tumorigenesis due to Cr(VI) include decreased cell-substrate adhesion, alveolar macrophage suppression, chronic inflammation due to increased cytokine release, direct DNA damage, and disrupted cell cycle progression leading to fibrosis, epithelial and alveolar hyperplasia, and cellular atypia.<xref ref-type="bibr" rid="article-147469.r4">[4]</xref><xref ref-type="bibr" rid="article-147469.r11">[11]</xref>&#x000a0;Occupational asthma via an IgE antibody-mediated mechanism has been reported 36 months after inhalational exposure to Cr(VI).<xref ref-type="bibr" rid="article-147469.r7">[7]</xref></p>
        <p>
<bold>Integumentary System</bold>
</p>
        <p>Cr(VI) is a skin sensitizer of similar potency to phenylenediamine and hexamethyl-diisocyanate and has&#x000a0;been known to cause dermal irritation and ulceration, particularly on damaged skin.<xref ref-type="bibr" rid="article-147469.r4">[4]</xref><xref ref-type="bibr" rid="article-147469.r5">[5]</xref><xref ref-type="bibr" rid="article-147469.r7">[7]</xref>&#x000a0;Dermal injury occurs via a type IV delayed hypersensitivity reaction; Cr(VI) conjugates with epidermal proteins&#x000a0;and interacts with T lymphocytes. Repeat exposures release inflammatory mediators.<xref ref-type="bibr" rid="article-147469.r7">[7]</xref>&#x000a0;Other studies have demonstrated that dermal exposure to Cr(VI) results in the increased expression of messenger RNA for interleukins 4 and 6 and immune interferon (IFN-&#x003b3;), type I IGE-mediated hypersensitivity reactions, elevated cholesterol synthesis, and inhibition of DNA damage repair.<xref ref-type="bibr" rid="article-147469.r4">[4]</xref>&#x000a0;</p>
        <p>
<bold>Gastrointestinal System</bold>
</p>
        <p>Gastrointestinal chromium exposure seems to be associated with lower toxicity due to the protective mechanisms detailed. Nevertheless, oxidative stress due to Cr(VI) led to villous vacuolization and apoptosis, crypt hyperplasia, and villous nuclear aberrancy in one animal study.<xref ref-type="bibr" rid="article-147469.r1">[1]</xref>&#x000a0;Ingestion of chromate salts can cause mucosal burns and irritation similar to dermal toxicity.<xref ref-type="bibr" rid="article-147469.r5">[5]</xref>&#x000a0;Additionally, gastrointestinal exposure has been associated with abnormal liver function, cell cycle acceleration, brush border impairment, and disruption in cell polarity in molecular pathway analysis.<xref ref-type="bibr" rid="article-147469.r4">[4]</xref>&#x000a0;&#x000a0;</p>
        <p>
<bold>Central and Peripheral Nervous Systems</bold>
</p>
        <p>In the central nervous system, Cr(VI) accumulates over the lifespan; studies suggest children and older adults are particularly vulnerable.<xref ref-type="bibr" rid="article-147469.r2">[2]</xref>&#x000a0;Animal studies have demonstrated acetylcholinesterase dysfunction and neurodegeneration in addition to oxidative stress, and human studies have implicated chromium in social memory loss, depression, schizophrenia, autism, olfactory dysfunction, and polyneuropathy. Further study is needed to identify the extent and mechanisms of chromium neurotoxicity.<xref ref-type="bibr" rid="article-147469.r2">[2]</xref></p>
        <p>
<bold>Renal System</bold>
</p>
        <p>Massive exposures to hexavalent or trivalent chromium, defined in animal studies as &#x02265;15 mg/kg, cause acute tubular&#x000a0;injury via oxidative stress, primarily at the proximal convoluted tubule. Chronic long-term exposure to chromium may contribute to chronic renal failure in conjunction with other causes.<xref ref-type="bibr" rid="article-147469.r16">[16]</xref><xref ref-type="bibr" rid="article-147469.r17">[17]</xref></p>
        <p>
<bold>Embryonic Adverse Effects</bold>
</p>
        <p>Studies have shown that Cr(VI) crosses the placenta and can negatively affect fetal tissue development. Hexavalent chromium may also upregulate apoptosis in the placenta.<xref ref-type="bibr" rid="article-147469.r9">[9]</xref><xref ref-type="bibr" rid="article-147469.r18">[18]</xref>&#x000a0;In a murine study, high concentrations of Cr(III) blocked blastocyst formation. Low concentrations decreased blastocyst cell number and proliferation, induced oxidative stress and apoptosis, and disrupted post-implantation development.<xref ref-type="bibr" rid="article-147469.r19">[19]</xref></p>
      </sec>
      <sec id="article-147469.s5" sec-type="Toxicokinetics">
        <title>Toxicokinetics</title>
        <p>Absorption of chromium compounds may occur via inhalation, ingestion, and dermal or mucosal contact.</p>
        <p>Particle size plays an important role in inhalational absorption; larger, less soluble particles are associated with higher levels of chronic toxicity, and particles smaller than 5 &#x003bc;m are absorbed into the bloodstream or across the pharyngeal mucosa.<xref ref-type="bibr" rid="article-147469.r7">[7]</xref><xref ref-type="bibr" rid="article-147469.r11">[11]</xref>&#x000a0;Inhalational exposure to Cr(VI) results in selective distribution within the lung. Absorption into the bloodstream increases the Cr(VI) concentration in erythrocytes. Chronic exposure distributes Cr(VI) to the liver, bone, kidneys, and spleen.<xref ref-type="bibr" rid="article-147469.r7">[7]</xref>&#x000a0;Cr(VI)&#x000a0;may also cross the placenta into the fetal circulation and may be found in breast milk after inhalational exposure.<xref ref-type="bibr" rid="article-147469.r9">[9]</xref><xref ref-type="bibr" rid="article-147469.r7">[7]</xref><xref ref-type="bibr" rid="article-147469.r18">[18]</xref><xref ref-type="bibr" rid="article-147469.r20">[20]</xref>&#x000a0;Cr(VI) is reduced to Cr(III) in the lungs by ascorbate, glutathione, and alveolar macrophages.<xref ref-type="bibr" rid="article-147469.r7">[7]</xref><xref ref-type="bibr" rid="article-147469.r20">[20]</xref>&#x000a0;Trivalent chromium may be detectable in the lungs for decades after exposure.<xref ref-type="bibr" rid="article-147469.r7">[7]</xref><xref ref-type="bibr" rid="article-147469.r20">[20]</xref></p>
        <p>Dermal absorption of chromium compounds is facilitated by epidermal barrier compromise. Hexavalent chromium-containing compounds traverse the epidermal barrier more efficiently than those containing trivalent chromium; irritation and sensitization can occur with exposure to both.<xref ref-type="bibr" rid="article-147469.r4">[4]</xref><xref ref-type="bibr" rid="article-147469.r5">[5]</xref><xref ref-type="bibr" rid="article-147469.r7">[7]</xref></p>
        <p>Gastric juices reduce Cr (VI) in the stomach, and 2% to 10% of the ingested dose is absorbed as Cr(VI) in the duodenum, facilitated by intestinal bacteria. Trivalent chromium demonstrates low&#x000a0;oral absorption rates of less than 1%.<xref ref-type="bibr" rid="article-147469.r7">[7]</xref><xref ref-type="bibr" rid="article-147469.r20">[20]</xref>&#x000a0;Gastric juices are responsible for most Cr(VI) metabolism in the gastrointestinal tract; absorption in the duodenum accounts for the remainder.<xref ref-type="bibr" rid="article-147469.r1">[1]</xref><xref ref-type="bibr" rid="article-147469.r7">[7]</xref><xref ref-type="bibr" rid="article-147469.r20">[20]</xref></p>
        <p>Chromium excretion is primarily via urine and largely as Cr(III). As much as 80% of the chromium load is excreted by the kidneys after inhalational exposure, and the kidneys excrete 60% of a given dose within 6 hours of ingestion.<xref ref-type="bibr" rid="article-147469.r7">[7]</xref><xref ref-type="bibr" rid="article-147469.r20">[20]</xref>&#x000a0; Approximately 10% of ingested chromium is excreted via the biliary system; smaller amounts are excreted in breast milk, saliva, and sweat.<xref ref-type="bibr" rid="article-147469.r7">[7]</xref>&#x000a0;Elimination half-life varies, likely due to the extensive metabolism and distribution of Cr(VI) and a tendency of Cr(III) to become trapped intracellularly, extending its time to elimination.<xref ref-type="bibr" rid="article-147469.r20">[20]</xref></p>
      </sec>
      <sec id="article-147469.s6" sec-type="History and Physical">
        <title>History and Physical</title>
        <p>Patients who present with acute toxicity will likely have a history of occupational exposure, and therefore, an employment history is vital. Industries that either produce or use chromium are relevant. These industries include welding (especially stainless steel welding), petroleum refining, mining and ore processing, leather tanning, dye and pigment production (or their use, such as in textiles and art), construction, law enforcement, or military (weapons/ammunition), or agriculture.<xref ref-type="bibr" rid="article-147469.r2">[2]</xref><xref ref-type="bibr" rid="article-147469.r3">[3]</xref><xref ref-type="bibr" rid="article-147469.r4">[4]</xref><xref ref-type="bibr" rid="article-147469.r8">[8]</xref>&#x000a0;</p>
        <p>It is important to document the area&#x000a0;where&#x000a0;the patient was exposed, the available room ventilation, the type of respiratory protection worn, the circumstances of the exposure, and any decontamination that occurred before medical evaluation. Acute toxicity by dermal contact will likely present with chemical burns, blistering, ulceration, necrosis, or sloughing, depending upon the level of contamination, concentration of the compound, duration of exposure, and amount of personal protective equipment used.</p>
        <p>Cr (VI) should be suspected if the offending agent is a brightly colored solid or reddish liquid, as many Cr (VI) compounds are pigments.<xref ref-type="bibr" rid="article-147469.r2">[2]</xref><xref ref-type="bibr" rid="article-147469.r3">[3]</xref><xref ref-type="bibr" rid="article-147469.r10">[10]</xref><xref ref-type="bibr" rid="article-147469.r20">[20]</xref>&#x000a0;A Safety Data Sheet (SDS) can help determine if chromic acid, sodium chromate, calcium chromate, potassium chromate, potassium dichromate, or ammonium dichromate are present in the chemical exposure and at what concentration.<xref ref-type="bibr" rid="article-147469.r5">[5]</xref><xref ref-type="bibr" rid="article-147469.r20">[20]</xref>&#x000a0;Chronic dermal toxicity is more likely to present with hypersensitivity symptoms such as contact dermatitis, skin ulcerations, eczema, skin thickening, and keratoconjunctivitis with acute eye exposure.<xref ref-type="bibr" rid="article-147469.r20">[20]</xref></p>
        <p>Acute or chronic inhalation toxicity may be less common as many workplaces will have engineering and personal protective equipment controls due to OSHA, NIOSH, and WHO standards and regulations meant to limit occupational exposures.&#x000a0;<xref ref-type="bibr" rid="article-147469.r6">[6]</xref>&#x000a0;However, signs of lung inflammation and respiratory irritation in acute exposure, such as cough, dyspnea, rhinorrhea, wheezing, choking, bronchospasm, and asthma exacerbation are expected.<xref ref-type="bibr" rid="article-147469.r5">[5]</xref><xref ref-type="bibr" rid="article-147469.r7">[7]</xref><xref ref-type="bibr" rid="article-147469.r11">[11]</xref><xref ref-type="bibr" rid="article-147469.r20">[20]</xref>&#x000a0;</p>
        <p>Subacute or chronic inhalation exposures are well-known to cause nasal ulceration, nasal septal perforation, and epistaxis, in addition to occupational asthma and rhinitis. They may ultimately predispose the patient to squamous cell carcinoma of the lung due to ongoing oxidative damage.<xref ref-type="bibr" rid="article-147469.r20">[20]</xref>&#x000a0;Non-respiratory symptoms associated with inhalation exposure to Cr (VI) include gastric ulcers, gastritis, colitis, dizziness, headache, weakness, abnormal sperm count, and motility.<xref ref-type="bibr" rid="article-147469.r20">[20]</xref>&#x000a0;Vitamin B12 and folate deficiencies have also been reported, although the mechanism of this toxicity is unclear.<xref ref-type="bibr" rid="article-147469.r20">[20]</xref></p>
        <p>Ingestions of Cr (VI) may present with caustic mucosal burns, pulmonary edema, GI bleeding, ulcers, gastritis, indigestion, anemia, leukocytosis, and bronchitis in larger doses due to accidental or intentional ingestion but are likely to be asymptomatic or exhibit mild symptoms at the smaller doses seen in occupational exposures due to detoxification via gastric juice.<xref ref-type="bibr" rid="article-147469.r1">[1]</xref><xref ref-type="bibr" rid="article-147469.r5">[5]</xref><xref ref-type="bibr" rid="article-147469.r20">[20]</xref>&#x000a0;</p>
        <p>Due to its low bioavailability, acute Cr (III) toxicity by ingestion is unlikely. Still, it may reduce iron absorption and cause symptoms of anemia and rhabdomyolysis at large doses.<xref ref-type="bibr" rid="article-147469.r14">[14]</xref><xref ref-type="bibr" rid="article-147469.r20">[20]</xref>&#x000a0;Patients may report a history of chromium supplement use for weight loss or glucose regulation; these preparations contain chromium picolinate or chromium chloride, forms of trivalent chromium.<xref ref-type="bibr" rid="article-147469.r7">[7]</xref><xref ref-type="bibr" rid="article-147469.r10">[10]</xref><xref ref-type="bibr" rid="article-147469.r14">[14]</xref>&#x000a0;</p>
        <p>Hepatotoxicity from ingestion may present as jaundice, hyperbilirubinemia, elevated lactate dehydrogenase, and transaminitis, and nephrotoxicity may demonstrate acute renal failure, proteinuria, hematuria, and anuria with both Cr (III) and Cr (VI) toxicity as the kidneys are the primary organs of excretion for chromium compounds.<xref ref-type="bibr" rid="article-147469.r16">[16]</xref><xref ref-type="bibr" rid="article-147469.r17">[17]</xref><xref ref-type="bibr" rid="article-147469.r20">[20]</xref>&#x000a0;Chronic ingestion toxicity has been associated with liver and stomach cancers.<xref ref-type="bibr" rid="article-147469.r20">[20]</xref>&#x000a0;Other malignancies associated with chromium toxicity include laryngeal, bladder, kidney, lymphoma, leukemia, pancreatic, thyroid, bone, and testicular cancers.<xref ref-type="bibr" rid="article-147469.r2">[2]</xref><xref ref-type="bibr" rid="article-147469.r11">[11]</xref><xref ref-type="bibr" rid="article-147469.r12">[12]</xref><xref ref-type="bibr" rid="article-147469.r14">[14]</xref><xref ref-type="bibr" rid="article-147469.r15">[15]</xref></p>
      </sec>
      <sec id="article-147469.s7" sec-type="Evaluation">
        <title>Evaluation</title>
        <p>Whole blood, plasma, and urinary chromium levels are all available but likely to be a send-out analysis and less helpful in managing acute toxicity. However, they may be beneficial in detecting or managing chronic occupational exposures. Blood and plasma chromium have a normal range of 0.10 mcg/L to 0.16 mcg/L, while urinary chromium excretion is approximately 0.22 mcg/L.<xref ref-type="bibr" rid="article-147469.r20">[20]</xref></p>
        <p>Regarding detection of acute and chronic toxicity, absorbed Cr (III) has an elimination half-life of 40 hours and reaches 95% steady state in 7 days, while Cr (VI) has a half-time of 30 days with a 95% steady state of 130 days due to RBC sequestration and slow release as erythrocytes die and are replaced.<xref ref-type="bibr" rid="article-147469.r20">[20]</xref></p>
      </sec>
      <sec id="article-147469.s8" sec-type="Treatment / Management">
        <title>Treatment / Management</title>
        <p>Overall, treatment of acute toxicity is supportive. Immediate treatment of chromium toxicity involves environmental removal to provide fresh air. Also, consider humidified supplemental oxygen, ventilatory support, bronchodilators, and expectorants as needed.</p>
        <p>Recommendations for oral toxicity&#x000a0;include avoidance of bicarbonate, antacids, and induction of vomiting. Clinicians can consider oral ascorbate or gastric lavage. Treatment of dermal toxicity involves mechanical decontamination, washing, and eye irrigation as needed, and calcium disodium edetate (EDTA) can be considered a binding agent. Finally, several treatments can be considered to increase the elimination of chromium from the body, including hemodialysis, ascorbic acid, N-acetylcysteine, and calcium EDTA.<xref ref-type="bibr" rid="article-147469.r20">[20]</xref>&#x000a0;Hemodialysis can be helpful in the case of massive exposures to chromium to ensure rapid and effective elimination.</p>
        <p>Other agents have preliminarily demonstrated some efficacy in animal studies, primarily due to proposed and demonstrated antioxidant effects. These include selenium, vitamin E, zinc, and melatonin. However, no studies have yet demonstrated that higher doses of antioxidants reduce adverse effects of chromium compounds in humans.<xref ref-type="bibr" rid="article-147469.r2">[2]</xref><xref ref-type="bibr" rid="article-147469.r8">[8]</xref><xref ref-type="bibr" rid="article-147469.r13">[13]</xref>&#x000a0;Regardless, occupationally exposed individuals are encouraged to consume foods rich in vitamin C (ascorbate), vitamin E, vitamin B6, folate, selenium, and zinc to reduce overall oxidative stress and ameliorate the effects of Cr (III) and Cr (VI) exposure.<xref ref-type="bibr" rid="article-147469.r13">[13]</xref></p>
      </sec>
      <sec id="article-147469.s9" sec-type="Differential Diagnosis">
        <title>Differential Diagnosis</title>
        <p>Occupational exposure&#x000a0;is a key historical component in diagnosing chromium toxicity due to its relatively nonspecific and wide-ranging effects on the body&#x02014;moreover, many other chemicals in the industrial setting cause similar symptoms. For example, other acids or vesicants will cause similar chemical burns with dermal exposure. Ultraviolet exposure may cause similar keratitis in welders. Eczema and asthma may be exacerbated by a myriad of other factors or be idiopathic. Increased respiratory secretions, vomiting, diarrhea, wheezing, and bronchospasm may be seen with cholinergic toxicity. Epistaxis and septal perforation can be seen with many nasal irritants. Hydrocarbons and volatile compounds will cause constitutional symptoms such as dizziness, weakness, and malaise. Other heavy metals such as mercury, lead, cadmium, and arsenic are also known to cause damage by oxidative stress and increase the risk of mutagenicity and cancer development.<xref ref-type="bibr" rid="article-147469.r15">[15]</xref>&#x000a0;</p>
        <p>Clinical suspicion should be high when a history is given of fluctuating symptoms throughout the day or week, especially on workdays. Also, recreational exposure to chromium-containing compounds through hobbies can be a source of clinically significant exposure.</p>
        <p>Chronic toxicity is more subtle, but any new diagnosis of cancer should include a detailed occupational history, including chromium, especially squamous cell carcinoma of the lungs, and gastric and liver malignancies. Excessive chromium supplementation should be considered an etiology of gastric ulcers, hepatotoxicity, and anemia.</p>
      </sec>
      <sec id="article-147469.s10" sec-type="Prognosis">
        <title>Prognosis</title>
        <p>The prognosis for acute chromium toxicity is generally excellent, with deaths noted primarily from massive ingestions.<xref ref-type="bibr" rid="article-147469.r20">[20]</xref>&#x000a0;Cancerous lesions due to chronic toxicity, however, may go undetected until the advanced disease burden causes systemic symptoms. One study estimated an overall mortality of 6 in 1,000 workers due to lung cancer at an exposure level of 1 mcg/m<sup>3</sup>.<xref ref-type="bibr" rid="article-147469.r13">[13]</xref>&#x000a0;High clinical suspicion and careful occupational history may aid in early detection and improved prognosis.</p>
      </sec>
      <sec id="article-147469.s11" sec-type="Complications">
        <title>Complications</title>
        <p>Long-term complications include scarring from skin and mucosal burns, dermal sensitization and asthma due to dermal or inhalation toxicity, and decreased nutrient and vitamin absorption due to gastrointestinal toxicity. There is also an increased risk of anemia, chronic liver disease, chronic kidney disease, and a lifetime increased risk of cancer.<xref ref-type="bibr" rid="article-147469.r2">[2]</xref><xref ref-type="bibr" rid="article-147469.r4">[4]</xref><xref ref-type="bibr" rid="article-147469.r5">[5]</xref><xref ref-type="bibr" rid="article-147469.r7">[7]</xref></p>
      </sec>
      <sec id="article-147469.s12" sec-type="Deterrence and Patient Education">
        <title>Deterrence and Patient Education</title>
        <p>Deterrence occurs primarily through industrial hygiene measures in the occupational environment to reduce exposure. These include engineering controls such as industrial ventilation, administrative controls such as limits to exposure duration and restricted access to areas utilizing chromium, and personal protective equipment such as gloves, gowns, and respirators.</p>
        <p>Patients exposed to chromium in their workplace should be informed about the potential long-term effects of chromium toxicity and advised on monitoring options for early detection of complications. Patients who report taking chromium supplements should be informed of the risks and benefits associated with supplementation, counseled on potential side effects, and advised to follow the manufacturer's instructions to prevent overdose.</p>
      </sec>
      <sec id="article-147469.s13" sec-type="Enhancing Healthcare Team Outcomes ">
        <title>Enhancing Healthcare Team Outcomes </title>
        <p>Identifying and caring for individuals exposed to chromium involves multiple professionals.</p>
        <p>Industrial hygienists identify workplaces where occupational exposure exists, characterize and quantify the type and duration of exposure, and recommend and implement&#x000a0;measures to mitigate the exposure risks.</p>
        <p>State and federal officials, public health professionals, environmental specialists, and remediation specialists can further assist with occupational exposure and environmental contamination. These team members play a key role in public health by regulating industrial exposures and discharges.</p>
        <p>Respiratory therapy technicians, emergency clinicians, nephrologists, and nursing staff&#x000a0;are key personnel in managing acute toxicity within the healthcare environment. Subacute and chronic toxicity management benefits from the consults&#x000a0;with dietetics, allergy/immunology, hematology, oncology, otorhinolaryngology, occupational medicine, and primary care.</p>
        <p>Poison Control Centers and medical toxicologists can also help manage acute and chronic complications of chromium toxicity.</p>
      </sec>
      <sec id="article-147469.s14">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=147469&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=147469">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://mdsearchlight.com/health/chromium-toxicity/?utm_source=pubmedlink&#x00026;utm_campaign=MDS&#x00026;utm_content=147469">Click here for a simplified version.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/147469/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=147469">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <ref-list id="article-147469.s15">
        <title>References</title>
        <ref id="article-147469.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Sun</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Brocato</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Costa</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Oral Chromium Exposure and Toxicity.</article-title>
            <source>Curr Environ Health Rep</source>
            <year>2015</year>
            <month>Sep</month>
            <volume>2</volume>
            <issue>3</issue>
            <fpage>295</fpage>
            <page-range>295-303</page-range>
            <pub-id pub-id-type="pmid">26231506</pub-id>
          </element-citation>
        </ref>
        <ref id="article-147469.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Wise</surname>
                <given-names>JP</given-names>
              </name>
              <name>
                <surname>Young</surname>
                <given-names>JL</given-names>
              </name>
              <name>
                <surname>Cai</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Cai</surname>
                <given-names>L</given-names>
              </name>
            </person-group>
            <article-title>Current understanding of hexavalent chromium [Cr(VI)] neurotoxicity and new perspectives.</article-title>
            <source>Environ Int</source>
            <year>2022</year>
            <month>Jan</month>
            <volume>158</volume>
            <fpage>106877</fpage>
            <pub-id pub-id-type="pmid">34547640</pub-id>
          </element-citation>
        </ref>
        <ref id="article-147469.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Tchounwou</surname>
                <given-names>PB</given-names>
              </name>
              <name>
                <surname>Yedjou</surname>
                <given-names>CG</given-names>
              </name>
              <name>
                <surname>Patlolla</surname>
                <given-names>AK</given-names>
              </name>
              <name>
                <surname>Sutton</surname>
                <given-names>DJ</given-names>
              </name>
            </person-group>
            <article-title>Heavy metal toxicity and the environment.</article-title>
            <source>Exp Suppl</source>
            <year>2012</year>
            <volume>101</volume>
            <fpage>133</fpage>
            <page-range>133-64</page-range>
            <pub-id pub-id-type="pmid">22945569</pub-id>
          </element-citation>
        </ref>
        <ref id="article-147469.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Shin</surname>
                <given-names>DY</given-names>
              </name>
              <name>
                <surname>Lee</surname>
                <given-names>SM</given-names>
              </name>
              <name>
                <surname>Jang</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Lee</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Lee</surname>
                <given-names>CM</given-names>
              </name>
              <name>
                <surname>Cho</surname>
                <given-names>EM</given-names>
              </name>
              <name>
                <surname>Seo</surname>
                <given-names>YR</given-names>
              </name>
            </person-group>
            <article-title>Adverse Human Health Effects of Chromium by Exposure Route: A Comprehensive Review Based on Toxicogenomic Approach.</article-title>
            <source>Int J Mol Sci</source>
            <year>2023</year>
            <month>Feb</month>
            <day>08</day>
            <volume>24</volume>
            <issue>4</issue>
            <pub-id pub-id-type="pmid">36834821</pub-id>
          </element-citation>
        </ref>
        <ref id="article-147469.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Gad</surname>
                <given-names>SC</given-names>
              </name>
            </person-group>
            <article-title>Acute and chronic systemic chromium toxicity.</article-title>
            <source>Sci Total Environ</source>
            <year>1989</year>
            <month>Oct</month>
            <day>01</day>
            <volume>86</volume>
            <issue>1-2</issue>
            <fpage>149</fpage>
            <page-range>149-57</page-range>
            <pub-id pub-id-type="pmid">2690338</pub-id>
          </element-citation>
        </ref>
        <ref id="article-147469.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Chen</surname>
                <given-names>QY</given-names>
              </name>
              <name>
                <surname>DesMarais</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Costa</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Metals and Mechanisms of Carcinogenesis.</article-title>
            <source>Annu Rev Pharmacol Toxicol</source>
            <year>2019</year>
            <month>Jan</month>
            <day>06</day>
            <volume>59</volume>
            <fpage>537</fpage>
            <page-range>537-554</page-range>
            <pub-id pub-id-type="pmid">30625284</pub-id>
          </element-citation>
        </ref>
        <ref id="article-147469.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Alvarez</surname>
                <given-names>CC</given-names>
              </name>
              <name>
                <surname>Bravo G&#x000f3;mez</surname>
                <given-names>ME</given-names>
              </name>
              <name>
                <surname>Hern&#x000e1;ndez Zavala</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Hexavalent chromium: Regulation and health effects.</article-title>
            <source>J Trace Elem Med Biol</source>
            <year>2021</year>
            <month>May</month>
            <volume>65</volume>
            <fpage>126729</fpage>
            <pub-id pub-id-type="pmid">33610058</pub-id>
          </element-citation>
        </ref>
        <ref id="article-147469.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Chakraborty</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Renu</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Eladl</surname>
                <given-names>MA</given-names>
              </name>
              <name>
                <surname>El-Sherbiny</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Elsherbini</surname>
                <given-names>DMA</given-names>
              </name>
              <name>
                <surname>Mirza</surname>
                <given-names>AK</given-names>
              </name>
              <name>
                <surname>Vellingiri</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Iyer</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Dey</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Valsala Gopalakrishnan</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Mechanism of chromium-induced toxicity in lungs, liver, and kidney and their ameliorative agents.</article-title>
            <source>Biomed Pharmacother</source>
            <year>2022</year>
            <month>Jul</month>
            <volume>151</volume>
            <fpage>113119</fpage>
            <pub-id pub-id-type="pmid">35613529</pub-id>
          </element-citation>
        </ref>
        <ref id="article-147469.r9">
          <label>9</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Singh</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Singh</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Verma</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Kamal</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Tiwari</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Sanjay Chivate</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Rai</surname>
                <given-names>SN</given-names>
              </name>
              <name>
                <surname>Kumar</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Singh</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Singh</surname>
                <given-names>MP</given-names>
              </name>
              <name>
                <surname>Vamanu</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Mishra</surname>
                <given-names>V</given-names>
              </name>
            </person-group>
            <article-title>Hexavalent-Chromium-Induced Oxidative Stress and the Protective Role of Antioxidants against Cellular Toxicity.</article-title>
            <source>Antioxidants (Basel)</source>
            <year>2022</year>
            <month>Nov</month>
            <day>30</day>
            <volume>11</volume>
            <issue>12</issue>
            <pub-id pub-id-type="pmid">36552581</pub-id>
          </element-citation>
        </ref>
        <ref id="article-147469.r10">
          <label>10</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>DesMarais</surname>
                <given-names>TL</given-names>
              </name>
              <name>
                <surname>Costa</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Mechanisms of Chromium-Induced Toxicity.</article-title>
            <source>Curr Opin Toxicol</source>
            <year>2019</year>
            <month>Apr</month>
            <volume>14</volume>
            <fpage>1</fpage>
            <page-range>1-7</page-range>
            <pub-id pub-id-type="pmid">31511838</pub-id>
          </element-citation>
        </ref>
        <ref id="article-147469.r11">
          <label>11</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Nickens</surname>
                <given-names>KP</given-names>
              </name>
              <name>
                <surname>Patierno</surname>
                <given-names>SR</given-names>
              </name>
              <name>
                <surname>Ceryak</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Chromium genotoxicity: A double-edged sword.</article-title>
            <source>Chem Biol Interact</source>
            <year>2010</year>
            <month>Nov</month>
            <day>05</day>
            <volume>188</volume>
            <issue>2</issue>
            <fpage>276</fpage>
            <page-range>276-88</page-range>
            <pub-id pub-id-type="pmid">20430016</pub-id>
          </element-citation>
        </ref>
        <ref id="article-147469.r12">
          <label>12</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ho</surname>
                <given-names>JH</given-names>
              </name>
              <name>
                <surname>Leikin</surname>
                <given-names>JB</given-names>
              </name>
              <name>
                <surname>Dargan</surname>
                <given-names>PI</given-names>
              </name>
              <name>
                <surname>Archer</surname>
                <given-names>JRH</given-names>
              </name>
              <name>
                <surname>Wood</surname>
                <given-names>DM</given-names>
              </name>
              <name>
                <surname>Brent</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Metal-on-Metal Hip Joint Prostheses: a Retrospective Case Series Investigating the Association of Systemic Toxicity with Serum Cobalt and Chromium Concentrations.</article-title>
            <source>J Med Toxicol</source>
            <year>2017</year>
            <month>Dec</month>
            <volume>13</volume>
            <issue>4</issue>
            <fpage>321</fpage>
            <page-range>321-328</page-range>
            <pub-id pub-id-type="pmid">28900863</pub-id>
          </element-citation>
        </ref>
        <ref id="article-147469.r13">
          <label>13</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Sijko</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Janasik</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>W&#x00105;sowicz</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Koz&#x00142;owska</surname>
                <given-names>L</given-names>
              </name>
            </person-group>
            <article-title>Can the effects of chromium compounds exposure be modulated by vitamins and microelements?</article-title>
            <source>Int J Occup Med Environ Health</source>
            <year>2021</year>
            <month>Aug</month>
            <day>05</day>
            <volume>34</volume>
            <issue>4</issue>
            <fpage>461</fpage>
            <page-range>461-490</page-range>
            <pub-id pub-id-type="pmid">33734217</pub-id>
          </element-citation>
        </ref>
        <ref id="article-147469.r14">
          <label>14</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Sawicka</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Jurkowska</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Piwowar</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Chromium (III) and chromium (VI) as important players in the induction of genotoxicity - current view.</article-title>
            <source>Ann Agric Environ Med</source>
            <year>2021</year>
            <month>Mar</month>
            <day>18</day>
            <volume>28</volume>
            <issue>1</issue>
            <fpage>1</fpage>
            <page-range>1-10</page-range>
            <pub-id pub-id-type="pmid">33775062</pub-id>
          </element-citation>
        </ref>
        <ref id="article-147469.r15">
          <label>15</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Balali-Mood</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Naseri</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Tahergorabi</surname>
                <given-names>Z</given-names>
              </name>
              <name>
                <surname>Khazdair</surname>
                <given-names>MR</given-names>
              </name>
              <name>
                <surname>Sadeghi</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Toxic Mechanisms of Five Heavy Metals: Mercury, Lead, Chromium, Cadmium, and Arsenic.</article-title>
            <source>Front Pharmacol</source>
            <year>2021</year>
            <volume>12</volume>
            <fpage>643972</fpage>
            <pub-id pub-id-type="pmid">33927623</pub-id>
          </element-citation>
        </ref>
        <ref id="article-147469.r16">
          <label>16</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Wedeen</surname>
                <given-names>RP</given-names>
              </name>
              <name>
                <surname>Qian</surname>
                <given-names>LF</given-names>
              </name>
            </person-group>
            <article-title>Chromium-induced kidney disease.</article-title>
            <source>Environ Health Perspect</source>
            <year>1991</year>
            <month>May</month>
            <volume>92</volume>
            <fpage>71</fpage>
            <page-range>71-4</page-range>
            <pub-id pub-id-type="pmid">1935854</pub-id>
          </element-citation>
        </ref>
        <ref id="article-147469.r17">
          <label>17</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Wu</surname>
                <given-names>YH</given-names>
              </name>
              <name>
                <surname>Lin</surname>
                <given-names>JC</given-names>
              </name>
              <name>
                <surname>Wang</surname>
                <given-names>TY</given-names>
              </name>
              <name>
                <surname>Lin</surname>
                <given-names>TJ</given-names>
              </name>
              <name>
                <surname>Yen</surname>
                <given-names>MC</given-names>
              </name>
              <name>
                <surname>Liu</surname>
                <given-names>YH</given-names>
              </name>
              <name>
                <surname>Wu</surname>
                <given-names>PL</given-names>
              </name>
              <name>
                <surname>Chen</surname>
                <given-names>FW</given-names>
              </name>
              <name>
                <surname>Shih</surname>
                <given-names>YL</given-names>
              </name>
              <name>
                <surname>Yeh</surname>
                <given-names>IJ</given-names>
              </name>
            </person-group>
            <article-title>Hexavalent chromium intoxication induces intrinsic and extrinsic apoptosis in human renal cells.</article-title>
            <source>Mol Med Rep</source>
            <year>2020</year>
            <month>Feb</month>
            <volume>21</volume>
            <issue>2</issue>
            <fpage>851</fpage>
            <page-range>851-857</page-range>
            <pub-id pub-id-type="pmid">31974625</pub-id>
          </element-citation>
        </ref>
        <ref id="article-147469.r18">
          <label>18</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Banu</surname>
                <given-names>SK</given-names>
              </name>
              <name>
                <surname>Stanley</surname>
                <given-names>JA</given-names>
              </name>
              <name>
                <surname>Sivakumar</surname>
                <given-names>KK</given-names>
              </name>
              <name>
                <surname>Arosh</surname>
                <given-names>JA</given-names>
              </name>
              <name>
                <surname>Taylor</surname>
                <given-names>RJ</given-names>
              </name>
              <name>
                <surname>Burghardt</surname>
                <given-names>RC</given-names>
              </name>
            </person-group>
            <article-title>Chromium VI - Induced developmental toxicity of placenta is mediated through spatiotemporal dysregulation of cell survival and apoptotic proteins.</article-title>
            <source>Reprod Toxicol</source>
            <year>2017</year>
            <month>Mar</month>
            <volume>68</volume>
            <fpage>171</fpage>
            <page-range>171-190</page-range>
            <pub-id pub-id-type="pmid">27443218</pub-id>
          </element-citation>
        </ref>
        <ref id="article-147469.r19">
          <label>19</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Tian</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Zhu</surname>
                <given-names>Q</given-names>
              </name>
              <name>
                <surname>Yuan</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Kneepkens</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Yue</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Zhang</surname>
                <given-names>C</given-names>
              </name>
            </person-group>
            <article-title>Direct embryotoxicity of chromium (III) exposure during preimplantation development.</article-title>
            <source>J Reprod Dev</source>
            <year>2021</year>
            <month>Aug</month>
            <day>27</day>
            <volume>67</volume>
            <issue>4</issue>
            <fpage>283</fpage>
            <page-range>283-291</page-range>
            <pub-id pub-id-type="pmid">34275971</pub-id>
          </element-citation>
        </ref>
        <ref id="article-147469.r20">
          <label>20</label>
          <element-citation publication-type="book">
            <person-group person-group-type="author">
              <name>
                <surname>Wilbur</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Abadin</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Fay</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Yu</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Tencza</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Ingerman</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Klotzbach</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>James</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <source>Toxicological Profile for Chromium</source>
            <publisher-name>Agency for Toxic Substances and Disease Registry (US)</publisher-name>
            <publisher-loc>Atlanta (GA)</publisher-loc>
            <year>2012</year>
            <month>09</month>
            <pub-id pub-id-type="pmid">24049864</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
